BIMI Holdings Price to Book Ratio 2010-2023 | BIMI
Historical price to book ratio values for BIMI Holdings (BIMI) over the last 10 years. The current price to book ratio for BIMI Holdings as of November 15, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| BIMI Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-09-25 | 0.01 | 0.01 | |
| 2023-09-30 | 1.57 | $1.52 | 1.03 |
| 2023-06-30 | 1.40 | $2.00 | 0.70 |
| 2023-03-31 | 0.55 | $2.14 | 0.26 |
| 2022-12-31 | 1.23 | $1.39 | 0.89 |
| 2022-09-30 | 2.84 | $2.66 | 1.07 |
| 2022-06-30 | 6.39 | $6.30 | 1.01 |
| 2022-03-31 | 13.80 | $12.93 | 1.07 |
| 2021-12-31 | 25.50 | $13.34 | 1.91 |
| 2021-09-30 | 35.95 | $53.65 | 0.67 |
| 2021-06-30 | 67.00 | $61.79 | 1.08 |
| 2021-03-31 | 87.50 | $60.78 | 1.44 |
| 2020-12-31 | 83.50 | $63.72 | 1.31 |
| 2020-09-30 | 84.00 | $63.81 | 1.32 |
| 2020-06-30 | 113.50 | $68.12 | 1.67 |
| 2020-03-31 | 124.00 | $44.66 | 2.78 |
| 2019-12-31 | 159.50 | $46.91 | 3.40 |
| 2019-09-30 | 54.50 | $60.74 | 0.90 |
| 2019-06-30 | 118.50 | $65.76 | 1.80 |
| 2019-03-31 | 310.00 | $63.80 | 4.86 |
| 2018-12-31 | 786.50 | $65.93 | 11.93 |
| 2018-09-30 | 235.00 | $157.66 | 1.49 |
| 2018-06-30 | 134.00 | $166.67 | 0.80 |
| 2018-03-31 | 71.00 | $186.84 | 0.38 |
| 2017-12-31 | 48.50 | $192.96 | 0.25 |
| 2017-09-30 | 46.50 | $191.70 | 0.24 |
| 2017-03-31 | 55.00 | $188.32 | 0.29 |
| 2016-12-31 | 43.26 | $188.80 | 0.23 |
| 2016-09-30 | 57.50 | $213.43 | 0.27 |
| 2016-06-30 | 37.45 | $220.19 | 0.17 |
| 2016-03-31 | 37.05 | $229.13 | 0.16 |
| 2015-12-31 | 36.50 | $231.78 | 0.16 |
| 2015-09-30 | 61.50 | $242.54 | 0.25 |
| 2015-06-30 | 77.50 | $253.33 | 0.31 |
| 2015-03-31 | 87.50 | $275.31 | 0.32 |
| 2014-12-31 | 79.50 | $273.94 | 0.29 |
| 2014-09-30 | 140.13 | $277.67 | 0.50 |
| 2014-06-30 | 132.50 | $275.86 | 0.48 |
| 2017-06-30 | 45.50 | $190.40 | 0.24 |
| 2013-12-31 | 79.50 | $283.54 | 0.28 |
| 2013-09-30 | 94.00 | $289.20 | 0.33 |
| 2013-06-30 | 31.95 | $289.15 | 0.11 |
| 2013-03-31 | 41.50 | $284.02 | 0.15 |
| 2012-12-31 | 50.86 | $279.83 | 0.18 |
| 2014-03-31 | 80.00 | $280.86 | 0.28 |
| 2012-09-30 | 34.55 | $278.13 | 0.12 |
| 2012-06-30 | 57.50 | $278.82 | 0.21 |
| 2012-03-31 | 47.00 | $278.40 | 0.17 |
| 2011-12-31 | 33.30 | $277.06 | 0.12 |
| 2011-09-30 | 38.05 | 0.00 | |
| 2011-06-30 | 82.78 | 0.00 | |
| 2011-03-31 | 163.01 | 0.00 | |
| 2010-12-31 | 250.53 | 0.00 | |
| 2010-09-30 | 325.00 | 0.00 | |
| 2010-06-30 | 318.75 | 0.00 | |
| 2010-03-31 | 500.00 | 0.00 | |
| 2009-12-31 | 525.00 | 0.00 | |
| 2009-09-30 | 575.00 | 0.00 | |
| 2009-06-30 | 318.75 | 0.00 | |
| 2009-03-31 | 82.50 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.012B |
| BIMI Holdings Inc. is a healthcare products and services provider, offering a broad range of healthcare products and related services principally in the U.S. and Asia. BIMI Holdings Inc., formerly known as BIMI International Medical Inc., is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $92.929B | 11.53 |
| Cencora (COR) | United States | $47.339B | 17.46 |
| DiDi Global (DIDIY) | China | $23.184B | 0.00 |
| Natera (NTRA) | United States | $19.283B | 0.00 |
| ICON (ICLR) | Ireland | $15.644B | 13.93 |
| Viatris (VTRS) | United States | $15.314B | 4.72 |
| Avantor (AVTR) | United States | $14.116B | 21.16 |
| Revvity (RVTY) | United States | $13.329B | 23.15 |
| BioMerieux (BMXMF) | France | $12.666B | 0.00 |
| CochLear (CHEOY) | Australia | $12.494B | 0.00 |
| Solventum (SOLV) | United States | $11.657B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.655B | 27.20 |
| Charles River Laboratories (CRL) | United States | $9.600B | 18.55 |
| Doximity (DOCS) | United States | $9.223B | 54.29 |
| HealthEquity (HQY) | United States | $8.643B | 46.91 |
| Sonic Healthcare (SKHHY) | Australia | $7.946B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.931B | 32.26 |
| Life Times (LTH) | United States | $4.907B | 32.48 |
| Sotera Health (SHC) | United States | $4.053B | 21.68 |
| Organon (OGN) | United States | $3.871B | 3.90 |
| BrightSpring Health Services (BTSG) | United States | $3.418B | 72.70 |
| Surgery Partners (SGRY) | United States | $2.917B | 33.26 |
| PACS (PACS) | United States | $2.653B | 0.00 |
| Concentras Parent (CON) | United States | $2.614B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.371B | 0.00 |
| Premier (PINC) | United States | $2.252B | 11.24 |
| Alignment Healthcare (ALHC) | United States | $2.202B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.880B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.586B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.582B | 41.50 |
| Pediatrix Medical (MD) | United States | $1.215B | 11.89 |
| Progyny (PGNY) | United States | $1.173B | 23.74 |
| CareDx (CDNA) | United States | $1.135B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.058B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.902B | 6.11 |
| Embecta (EMBC) | United States | $0.844B | 5.62 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.713B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.712B | 0.00 |
| Agilon Health (AGL) | United States | $0.651B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 0.00 |
| DocGo (DCGO) | United States | $0.417B | 15.73 |
| Sonida Senior Living (SNDA) | United States | $0.411B | 0.00 |
| Enhabit (EHAB) | United States | $0.370B | 31.96 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.345B | 0.00 |
| LifeMD (LFMD) | United States | $0.238B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 12.61 |
| Sera Prognostics (SERA) | United States | $0.205B | 0.00 |
| Biodesix (BDSX) | United States | $0.196B | 0.00 |
| Beauty Health (SKIN) | United States | $0.190B | 0.00 |
| Nutex Health (NUTX) | United States | $0.156B | 0.00 |
| MultiPlan (MPLN) | United States | $0.100B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.20 |
| Singular Genomics Systems (OMIC) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.044B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.022B | 0.00 |
| Oncology Institute (TOI) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |